Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report
- PMID: 28521004
- PMCID: PMC5731448
- DOI: 10.1093/jtm/tax026
Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report
Abstract
Background: : Travelers' diarrhea causes significant morbidity including some sequelae, lost travel time and opportunity cost to both travelers and countries receiving travelers. Effective prevention and treatment are needed to reduce these negative impacts.
Methods: : This critical appraisal of the literature and expert consensus guideline development effort asked several key questions related to antibiotic and non-antibiotic prophylaxis and treatment, utility of available diagnostics, impact of multi-drug resistant (MDR) colonization associated with travel and travelers' diarrhea, and how our understanding of the gastrointestinal microbiome should influence current practice and future research. Studies related to these key clinical areas were assessed for relevance and quality. Based on this critical appraisal, guidelines were developed and voted on using current standards for clinical guideline development methodology.
Results: : New definitions for severity of travelers' diarrhea were developed. A total of 20 graded recommendations on the topics of prophylaxis, diagnosis, therapy and follow-up were developed. In addition, three non-graded consensus-based statements were adopted.
Conclusions: : Prevention and treatment of travelers' diarrhea requires action at the provider, traveler and research community levels. Strong evidence supports the effectiveness of antimicrobial therapy in most cases of moderate to severe travelers' diarrhea, while either increasing intake of fluids only or loperamide or bismuth subsalicylate may suffice for most cases of mild diarrhea. Further studies are needed to address knowledge gaps regarding optimal therapies, the individual, community and global health risks of MDR acquisition, manipulation of the microbiome in prevention and treatment and the utility of laboratory testing in returning travelers with persistent diarrhea.
Keywords: Clinical practice guideline; emporiatrics; evidence-based medicine.
Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US.
Figures
Comment in
-
Comment on 'Guidelines for the prevention of and treatment of travelers' diarrhea: a graded expert panel report by Riddle et al.'.J Travel Med. 2017 Sep 1;24(6). doi: 10.1093/jtm/tax054. J Travel Med. 2017. PMID: 28922822 No abstract available.
-
Travelers' diarrhea in children: a blind spot in the expert panel guidelines on prevention and treatment.J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax075. J Travel Med. 2018. PMID: 29394391 No abstract available.
References
-
- Steffen R, Hill DR, DuPont HL.. Traveler's diarrhea: a clinical review. JAMA 2015; 313:71–80. - PubMed
-
- Travelers' diarrhea. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement 1985; 5:1–7. - PubMed
-
- Riddle MS, Arnold S, Tribble DR.. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008; 47:1007–14. - PubMed
-
- Zaidi D, Wine E.. An update on travelers' diarrhea. Curr Opin Gastroenterol 2015; 31:7–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical